Dabur, HDFC Life, Hero Motocorp To Make Stock Market Shine Today

The last two days have witnessed a slow momentum of the stock market. Experts say that the global trends may cause ups and downs in the market even today

Zydus Cadila, Taiwan's TLC Ink Pact To Market Black Fungus Drug In India

Shares of Cadila Healthcare, the listed entity of Zydus Group, were trading at Rs 626.45 per scrip on BSE, up 0.64 per cent from the previous close.

Zydus Cadila Gets USFDA Nod To Market Anti-Arrhythmic Drug

Shares of Cadila Healthcare were trading 1.18 per cent higher at Rs 558.75 apiece on BSE.

Indian Pharma Industry's COVID-19 Vaccine Plans

India, which has itself been badly hit by the pandemic with nearly 10 million infections, the second-highest in the world, is focusing on affordable vaccines instead of the expensive messenger RNA shots of Pfizer Inc and Moderna Inc.

India reports 41,322 new COVID-19 cases; PM reviews development, manufacturing of vaccine in 3 cities

India reports 41,322 new COVID-19 cases; PM reviews development, manufacturing of vaccine in 3 cities

Zydus Begins Human Trials For Potential COVID-19 Vaccine

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

India Approves Human Trials For Second COVID-19 Vaccine Candidate

India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.

Zydus Acquires Select Brands Of Leading Animal Health Co Zoetis

Ahmedabad-based integrated pharmaceutical player Cadila Healthcare Ltd has said that it has acquired select brands and the Haridwar manufacturing unit of Zoetis, which was spun off Pfizer in 2013, for an undisclosed sum

UCB Files Cases Against Ranbaxy, Sun Pharma, Others On Patent Issue